» Articles » PMID: 12966207

Expression of FGF Receptors 1, 2, 3 in the Embryonic and Postnatal Mouse Brain Compared with Pdgfralpha, Olig2 and Plp/dm20: Implications for Oligodendrocyte Development

Overview
Journal Dev Neurosci
Specialty Neurology
Date 2003 Sep 11
PMID 12966207
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Fibroblast growth factors (FGF) receptors FgfR1, FgfR2 and FgfR3 are differentially regulated during oligodendrocyte (OL) maturation in vitro: FgfR3 is expressed by OL progenitors whereas FgfR2 is expressed by differentiated OLs [Mol Cell Neurosci 1996;7:263-275], and we have recently shown that FgfR3 is required for the timely differentiation of OLs in vivo [J Neurosci 2003;23:883-894]. Here we have used in situ hybridization to investigate the expression patterns of FgfR1-3 and compare them to the putative OL progenitor markers Olig2, Pdgfralpha and Plp/dm20 as a function of development in vivo, in particular at sites of OL specification, migration or differentiation in the mouse forebrain and cerebellum. We show that at early stages FgfR1-3 expression overlaps with that of Olig2 in the embryonic ventricular zone of the lateral and medial ganglionic eminences. Further, a scattered population of cells expressing FgfR3 (but not FgfR1 or FgfR2) in the ventral telencephalon appear to arise from the ventricular zone, and at later stages are found more dorsally in the cortex, in an overall pattern similar to Olig2 and/or Pdgfralpha. Postnatal expression of FgfR2 increases with age, more prominently in specific regions, including the cortical and cerebellar white matter and optic nerve. Thus, the differential expression pattern of FgfR2 and FgfR3 observed in vivo suggests that their expression is developmentally regulated in a manner consistent with the pattern of their expression in culture. These data provide further insights into role of FgfRs in OL development, and they emphasize that these receptors are positioned both spatially and temporally to impact OL generation in vivo.

Citing Articles

Phenotypic and epigenetic heterogeneity in FGFR2-fused glial and glioneuronal tumours.

Metais A, Dangouloff-Ros V, Garcia J, Vannod-Michel Q, Csanyi M, Tauziede-Espariat A Neuropathol Appl Neurobiol. 2024; 50(6):e13014.

PMID: 39511841 PMC: 11618513. DOI: 10.1111/nan.13014.


Diverse Responses of Oligodendrocytes to Different FGF-Family Members: Uncoupling Structure-Function Relationship Within FGF Subfamilies.

Guardiola-Diaz H, DiBenedictis B, Prendaj E, Bansal R ASN Neuro. 2024; 16(1):2371163.

PMID: 39024549 PMC: 11262039. DOI: 10.1080/17590914.2024.2371163.


FGF/FGFR system in the central nervous system demyelinating disease: Recent progress and implications for multiple sclerosis.

Zhang Q, Chen Z, Zhang K, Zhu J, Jin T CNS Neurosci Ther. 2023; 29(6):1497-1511.

PMID: 36924298 PMC: 10173727. DOI: 10.1111/cns.14176.


FGFR3 overactivation in the brain is responsible for memory impairments in Crouzon syndrome mouse model.

Cornille M, Moriceau S, Khonsari R, Heuze Y, Loisay L, Boitez V J Exp Med. 2022; 219(4).

PMID: 35254402 PMC: 8906494. DOI: 10.1084/jem.20201879.


Genesis of the Master Circadian Pacemaker in Mice.

Cheng A, Cheng H Front Neurosci. 2021; 15:659974.

PMID: 33833665 PMC: 8021851. DOI: 10.3389/fnins.2021.659974.